| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Interpace Biosciences Inc
Interpace Biosciences Inc
OTC:IDXG
Interpace Biosciences Inc
Net Change in Cash
Interpace Biosciences Inc
Net Change in Cash Peer Comparison
DVA
DGX
CVS
CI
LH
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Interpace Biosciences Inc
OTC:IDXG
|
Net Change in Cash
-$2.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
5%
|
CAGR 10-Years
16%
|
|
|
DaVita Inc
NYSE:DVA
|
Net Change in Cash
$19.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-26%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Change in Cash
$299m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
40%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Change in Cash
-$4.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Net Change in Cash
$2.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Change in Cash
-$294.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-87%
|
CAGR 10-Years
N/A
|
See Also
What is Interpace Biosciences Inc's Net Change in Cash?
Net Change in Cash
-2.8m
USD
Based on the financial report for Mar 31, 2024, Interpace Biosciences Inc's Net Change in Cash amounts to -2.8m USD.
What is Interpace Biosciences Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
16%
The average annual Net Change in Cash growth rates for Interpace Biosciences Inc have been 35% over the past three years , 5% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
